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Abstract
Context: Nanotechnology can be applied to deliver and protect antioxidants in order to control
the oxidative stress phenomena in several chronic pathologies. Chitosan (CS) nanoparticles are
biodegradable carriers that may protect antioxidants with potent biological activity such as
rosmarinic acid (RA) in Salvia officinalis (sage) and Satureja montana (savory) extracts for safe
and innovative therapies.
Objective: Development and characterization of CS nanoparticles as a stable and protective
vehicle to deliver RA for medical applications using natural extracts as sage and savory.
Materials and methods: Antioxidant-CS based nanoparticles were prepared by ionic gelation
with sodium tripolyphosphate (TPP), at pH 5.8 with a mass ratio of 7:1 (CS:TPP), with a
theoretical antioxidant-CS loading of 40–50%. The nanoparticles were then characterized by
different methods such as photon correlation spectroscopy, laser Doppler anemometry,
scanning electron microscopy (SEM), differential scanning calorimetry (DSC), Fourier-transform
infrared (FTIR), high-performance liquid chromatographic (HPLC), association efficiency, and
antioxidant activity.
Results and discussion: Individual and small sizing nanoparticles, around 300 nm, were obtained.
SEM confirmed smooth and spherical nanoparticles after freeze-drying. No chemical
interactions were found between antioxidants and CS, after encapsulation, by DSC and FTIR.
The association efficiency was 51.2% for RA (with 40% loading) and 96.1 and 98.2% for sage and
savory nanoparticles, respectively (both with 50% loading). Antioxidant activity values were
higher than 0.0348 eq [Asc. Ac.] g/L/g extract and 0.4251 mmol/eq Trolox/g extract.
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Introduction
Salvia officinalis and Satureja montana (sage and savory,
respectively) are plants often used in the traditional medicine
to improve digestion (Gião et al., 2009), as an disinfectant
(Djenane et al., 2011), to decrease blood pressure (Petersen &
Simmonds, 2003), to prevent premature ejaculation (Zavatti
et al., 2011), to treat neuropathy (Abada et al., 2011), urinary
and pulmonary infections (Cardilea et al., 2009), and other
diseases such as Alzheimer’s disease (Zhoua et al., 2011) and
cancer (Cardilea et al., 2009). Some of these biological
activities have been associated with its high contents in RA
(Gião et al., 2009; Shahidi et al., 1992; Skoula et al., 2000).
RA (a-O-caffeoyl-3,4-dihydroxyphenillactic acid) is a phen-
olic compound generally admitted as a free radical scavenger
(Fadel et al., 2011). The high biological activity is related to
its chemical structure, in particular the two catechol moieties.
Catechol is an important sub-structure for the potent antioxi-
dant activity of phenolic antioxidants (Fadel et al., 2011). The
general antioxidant mechanism of phenolic compounds is
thought to be divided into two stages: radical catching stage
and radical conclusion stage (Fujimoto & Masuda, 2012). The
structure of the final product would afford important infor-
mation about the antioxidant mechanism of the phenolics
(Fujimoto & Masuda, 2012). RA can have many beneficial
functionalities like its potent antioxidant activity associated to
its huge potential radical scavenging activity, higher than
trolox (a derivative of a-tocopherol), commonly used as a
control. Its antibacterial and antiviral activity, anti-inflam-
matory activity (Huang et al., 2009), anti-mutagenicity
character (Furtado et al., 2008), capability to reduce atopic
dermatitis symptoms (Lee et al., 2008), prevention of
Alzheimer’s disease (Hamaguchi et al., 2009), and apoptosis
induction of colorectal cancer cells (Xavier et al., 2009) are
also well documented. Nevertheless, besides the lower
partition coefficients and poor absorption that constrain the
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transport across biological barriers, most of the natural
antioxidants or other active compounds are unstable and must
be protected from degradation in the physiological environ-
ment (Hou et al., 2012). Thus, the efficacy of these drugs
clearly depends on the design of appropriate carriers for their
delivery, protection, and release (Prabaharan & Mano, 2005).
Among the different approaches explored so far, colloidal
carriers of particular interest, especially those made of
mucoadhesive polymers, assure drug time retention at the
absorption site (Campos et al., 2004). For this application,
chitosan (CS) has become of particularly interesting for the
association and delivery of labile macromolecular compounds
(Silva et al., 2011). CS nanoparticle carriers have an
exceptional potential for drug delivery, especially for muco-
sal, since these systems are stable in contact with physio-
logical fluids and barriers, control drug release, and protect
against adverse conditions like mucosal enzymes and bio-
logical protective fluids (Silva et al., 2011). The smart
symbiosis of these CS nanoparticles with a high potent
antioxidant could be a hope for future therapies, considering
the important effect of oxidative stress in several chronic
pathologies. In this study, CS nanoparticles were used, to
incorporate natural extracts of Salvia officinalis and Satureja
montana as a stable and protective vehicle to deliver RA for
medical applications. There are no reports in the literature
that have demonstrated the good performance of CS
nanoparticles to incorporate these extracts in order to bring
the huge benefits of RA antioxidant, as well as, other
compounds that may act synergistically.
Materials and methods
Materials
The two selected plants sage and savory were provided by
ERVITAL (Castro Daire, Portugal), from a previous study
considering the potential antioxidant activity and the absence
of genotoxicity of over 48 medicinal plants performed by our
research group (Gião et al., 2007). The plants had been
cultivated as organic products and were supplied in the
commercial form of dried leaves. The dried leaves were then
kept in the dark at 20 C. RA (purity 96.5%), methanol
CHROMASOLV (HPLC 99.9%), and formic acid
(HPLC 9 8.0%) were purchased from Sigma-Aldrich
(Lisbon, Portugal). CS low molecular weight and sodium
tripolyphosphate (TPP) were also purchased from Sigma-
Aldrich (Lisbon, Portugal). The degree of deacetylation for the
low molecular weight (LMW) CS was 85%, with a purity grade
of 85%. Pure acetic acid was purchased from Pornalab (Lisbon,
Portugal). Sodium hydroxide (NaOH) and hydrochloric acid
(HCl) were from Merck (Darmstadt, Germany). Ultra-pure
water was obtained in the laboratory using a Millipore water
purification equipment (Millipore, Billerica, MA).
Sample preparation
The two plants, 1 g each, were crushed (using a lab mill) for
1 min, to obtain the corresponding powder. The extraction
powder was performed as described in previous reports, via
addition of 100 mL boiling water to 1 g of plant powder and
after 5 min, the extract was filtered through a 0.45mm filter
(Silva et al., 2013). This procedure was optimized to obtain
the highest potential activity of these plants. After the crude
plant sedimentation, samples were filtered and maintained at
80 C, for freeze-drying procedures (Heto Holten A/S
Drywinner, Allerød, Denmark). Then, solutions of 1% (w/v)
of freeze-dried powder were dissolved in methanol for
chromatographic analyses and in ultra-pure water for antioxi-
dant activity tests. Before injections, samples were filtered
again through a 0.45 mm filter.
CS nanoparticles development and optimization
CS-nanoparticles were developed and optimized based on the
previous studies. The CS nanoparticles were obtained by
inducing the gelation of a CS solution with TPP. For this
propose, TPP was dissolved in purified water, and CS was
dissolved in acetic acid aqueous solutions at various concen-
trations and pH was adjusted to 5.8 with 1 M NaOH. The
concentration of acetic acid was, in all cases, 1.75 times
higher than that of CS, as previously described (Calvo et al.,
1997). After several assays, considering the variation of
concentrations and volumes, an optimal ratio between
CS:TPP was achieved (7:1). This optimal ratio was considered
to achieve particles ranging (200–300 nm) using ZetaPALS
(Brookhaven Instruments Corp., New York, NY) and a charge
as close as possible of 30 mV by laser Doppler anemometry
(Brookhaven Instruments Corp., New York, NY), at 25 C. A
final volume of 2.0 mL of TPP solution was added to 5 mL of
the CS solution under magnetic stirring at room temperature,
thus achieving a final concentration of 2 and 0.28 mg/mL of
CS and TPP, respectively.
Encapsulation of sage, savory, and rosmarinic acid
into CS nanoparticles
The 1% (w/v) aqueous RA and aqueous extracts solutions
were added to CS, previously dissolved in acetic acid, in
different volumes in order to guarantee the best ratio between
CS and the different compounds, as documented previously
(Silva et al., 2013). For this concern, the encapsulation was
tested in different theoretical loadings (5, 10, 15, 20, 30, 40,
and 50%) fairly to the initial concentration of CS (2 mg/mL).
All the tests were made for the seven batches, considering the
two plants and the pure RA. Then, nanoparticles were freeze-
dried and maintained at 20 C for 1–2 months.
Association efficiency (AE)
AE was evaluated considering the amount of RA associated
with the particles. For this propose, the particles were
centrifuged (20 000 g/45 min) and suspended in 7 mL of
ultra-pure water. The AE was then calculated by the
difference between the total RA used to prepare the particles
and the amount of residual RA in the supernatant. AE of RA
in RA nanoparticles and sage and savory nanoparticles were
obtained according to the following equation:
AE% ¼ total amount free amount=total amountð Þ  100
In vitro release of rosmarinic acid from CS
nanoparticles
The release of RA from CS nanoparticles was tracked to
predict the diffusion and kinetic behavior of the nanosystems.
DOI: 10.3109/13880209.2014.935949 Chitosan nanocarriers for rosmarinic acid drug delivery 643
For release studies, loaded nanoparticles obtained after
centrifugation were suspended in 10 mL of a phosphate-
buffered saline (PBS) solution, pH 7.4. This nanoparticle
suspension was transferred to clean eppendorfs and placed in
a water bath at 37 C under stirring. After 0.5, 1, 2, 4, 6, and
24 h, samples were collected from the bath and centrifuged at
14 000 rpm for 5 min (BOECO, Hamburg, Germany).
Supernatants were analyzed by HPLC and used to calculate
the amount of RA released from the nanoparticles over the
specified time. Triplicate samples were analyzed at each time.
HPLC analysis and rosmarinic acid quantification
Chromatographic analysis was performed as described previ-
ously (Silva et al., 2013), using the Waters Series 600 HPLC
and results acquired and processed with Empower Software
2002 for data acquisition (Waters Corporation, Mildford,
MA), on a Nova-Pack RP C18 column (250 4.6 mm i.d.,
5 mm particle size, and 125 Å pore size) from Waters
Corporation (Mildford, MA), in a gradient mode with a
mobile phase comprising methanol:formic acid:water
92.5:2.5:5 (v/v) at a flow rate of 0.75 mL/min. The injection
volume was 20 mL and the detection wavelength was 280 nm.
For analysis and quantification of RA content in the extracts,
stock standard solutions of 2 mg/mL of RA were prepared
with methanol. The calibration curve was made from the
dilution of stock solutions in methanol of seven standard
(0.05, 0.1, 0.2, 0.3, 0.5, 0.8, and 1) mg/mL. The HPLC
method was validated according to the International
Conference on Harmonization (ICH, 2005) guidelines.
Size and surface charge
Size and polydispersity (size distribution) of freshly unloaded
and loaded nanoparticles were determined by photon correl-
ation spectroscopy using ZetaPALS (Brookhaven Instruments
Corporation, New York, NY). A sample of 1.6 mL was gently
homogenized, placed into analyzer chamber, and measured.
Collective six readings were performed three times on a
sample of particles at 25 C with a detection angle of 90 .
The zeta potential (surface charge) was determined by laser
Doppler anemometry (Brookhaven Instruments Corporation,
New York, NY), at 25 C. Triplicate samples were also
analyzed, each sample being measured six times, and the
arithmetic mean was adopted.
Morphology
Freeze-dried nanoparticles’ morphology such as shape and
occurrence of aggregation phenomena was studied by
scanning electron microscopy (SEM). Samples of nanoparti-
cles were mounted on metal stubs, gold coated under vacuum,
and then examined on a JEOL-5600 Lv microscope (Joel,
Tokyo, Japan). SEM was operated at the low vacuum mode,
using a spot size of 27–28 and a potential of 30 kV. All
analyses were performed at room temperature (20 C).
Differential scanning calorimetry analysis
Thermograms were obtained using a differential scanning
calorimetry (DSC) (DSC-60, Shimadzu, Columbia, MD).
Samples were freeze-dried, and 2.0 mg of the freeze-dried
powder were crimped in a standard aluminum pan and heated
from 20 to 350 C at a heating constant rate of 10 C/min
under constant purging of nitrogen at 20 mL/min. All samples
were run in triplicate and data presented are the average of the
three measurements.
Fourier-transform infrared analysis
Infrared spectroscopy analysis was performed in a ABB
MB3000 FTIR spectrometer (ABB, Zurich, Switzerland)
equipped with a horizontal attenuated total reflectance (ATR)
sampling accessory (PIKE Technologies, Madison, WI), the
Horizon MBTM FTIR software and a diamond/ZnSe crystal.
All spectra were acquired using 200 scans and a 4 cm1
resolution in the region of 4000–700 cm1. In order to
perform the spectra comparison, spectra were truncated at
1800 and 700 cm1, since this region displays typical
absorption bands for the used compounds. In addition,
baseline-point adjustment and spectra normalization were
performed. All samples were run in triplicate and data
presented are the average of the three measurements.
Antioxidant capacity assessment
ABTS
Determination of the antioxidant capacity was performed as
described in other research papers (Gião et al., 2007). The
ABTS.+ stock solution was prepared via addition, at 1:1
(v/v), of 7 mM ABTS (2,2-azinobis (3-ethylbenzothiazoline-
6-sulfonic) acid) diammonium salt (Sigma-Aldrich, St. Louis,
MO) to a solution of 2.45 mM potassium persulfate (Merck,
Darmstadt, Germany); the developing reaction took place in
the dark, for 16 h. In order to obtain an absorbance of
0.700 ± 0.020 at 734 nm, measured with an UV 1203
spectrophotometer (Shimadzu, Tokyo, Japan), the aforemen-
tioned stock solution was diluted in ultra-pure water as
necessary. A 10 mL aliquot of the sample was assayed for
percentage of inhibition (PI), to be between 20% and 80%, to
guarantee a linear response of the analytical method, after
6 min of reaction with 1 mL of diluted ABTS.+ solution.
The total antioxidant capacity was expressed as percentage
of inhibition (PI), according to the equation:
PI ¼ AbsABTS. þAbs sample
 
=AbsABTS.þÞ  100
where AbsABTS.+ denotes the initial absorbance of diluted
ABTS.+, and Abs sample denotes the absorbance of the
sample by 6 min of reaction. Triplicates of each sample were
averaged to generate each datum point (which implies a total
of six replicates per sample). The final result was expressed as
an equivalent concentration of ascorbic acid (in gL1), using a
calibration curve.
Oxygen radical absorbance capacity (ORAC)
The ORAC assay was employed to evaluate the antioxidant
potential of CS-antioxidant nanoparticles as described previ-
ously in reports (Contreras et al., 2011). All reaction mixtures
were prepared in duplicate, and at least three independent
measures were performed for each experiment. ORAC-
fluorescein (FL) values were expressed in mmol trolox
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equivalent per mg hydrolyzed of antioxidant, as proposed
elsewhere (Hernández-Ledesma et al., 2005).
Statistical analysis
Statistical analysis was performed using IBM SPSS Statistics
v 19.0.0 (SPSS Inc., Chicago, IL). The one-way analysis
of variance (ANOVA) was used with Scheffé post hoc test
comparison of groups with normal distribution, and the
Mann–Whitney test for groups with non-normal distribution.
Differences were considered to be significant at a level of
p50.05.
Results and discussion
Particle size, polydispersity, and zeta potential
Particle size and size distribution are important parameters
towards the development of suitable nanomedicines for
therapeutic purposes. They influence in vivo distribution,
biological fate, toxicity, and the targeting ability of nano-
particle systems (Kumari et al., 2010). In addition, they can
also influence the drug loading, drug release, and stability of
drug inside nanoparticles (Mohanraj & Chen, 2006).
Considering the nanoparticles’ charge, it is known that the
highest value of zeta potential represents the greater electro-
static repulsive interactions among the particles, the stability
will increase as well as the size distribution will be more
homogenous. Zeta potential values of ±30 mV indicate that
the colloidal system is stable in time and that amino groups of
CS are on the surface, which is also documented in some
similar studies of antioxidants encapsulation in CS nanopar-
ticles (Harris et al., 2011). The loaded nanoparticles under
study, ranging from 200 to 300 nm, and with zeta potential
from 20 to 30 (Table 1) showed no significant differences
(p50.05) between the different theoretical loadings for each
formulation and between the two crude extracts, which is in
accordance with the previous reports (Silva et al., 2013).
RA-nanoparticles at 50% theoretical loading were the only
exception, since their higher size (1218.0 ± 136.2) is not in the
range of nano-scale and, as a consequence, not considered for
the following tests. The extracts do not seem to interfere in the
size or zeta potential of the nanoparticles being a good vehicle
for RA nano-incorporation. The obtained nanoparticles also
showed values of polydispersity between 0.1 and 0.2 corres-
ponding to a narrow particle size distribution, and to
monodispersed particles. These results are in accordance
with other research works using similar antioxidant nanopar-
ticles (Liu et al., 2011).
Morphology
SEM images can directly provide information on the particle
size and morphology of nanoparticles. In this study, SEM
images were analyzed to prove that the size was maintained
after freeze dried (dehydration process). Figure 1 shows the
SEM images of freeze-dried CS nanoparticles prepared by
ionic gelation under the same pH conditions, for the
encapsulation of RA in a pure form, sage and savory.
The freeze-dried samples even with some aggregation of the
nanoparticles formed by dispersion during freeze drying
guarantee the nano-scale particles with the diameters under
1 mm, which is in accordance with other previous studies
(Wu et al., 2012). The microstructural analysis confirmed the
morphology and size of the nanoparticles. Other studies
Table 1. Zetasizer measurements and the association efficiency considering the different loading (%) of RA, sage, and savory nanoparticles (n¼ 3).
Size and surface charge Association efficiency
Nano
Loading











RA 5 230.0 ± 48.8a 0.155 ± 0.043 23.9 ± 5.5b 56.6 ± 3.6 100 43.4 ± 3.5c
10 242.4 ± 112.3a 0.215 ± 0.126 18.7 ± 2.3b 94.8 ± 6.1 200 52.6 ± 3.1c
15 229.5 ± 40.1a 0.142 ± 0.076 29.9 ± 9.9b 147.9 ± 54.8 300 50.7 ± 18.3c
20 231.1 ± 68.3a 0.149 ± 0.044 32.7 ± 6.4b 186.4 ± 52.0 400 53.4 ± 2.0c
30 261.8 ± 50.4a 0.171 ± 0.027 34.5 ± 4.5b 306.0 ± 39.2 600 49.0 ± 6.5c
40 244.0 ± 18.0a 0.193 ± 0.062 29.5 ± 1.6b 390.4 ± 41.0 800 51.2 ± 3.0c
50 1218.0 ± 136.2a 0.294 ± 0.132 35.0 ± 7.9b 422.0 ± 65.0 1000 57.8 ± 1.3c
Sage 5 330.9 ± 78.9a 0.137 ± 0.012 20.8 ± 0.6b 15.1 ± 0.4 100 84.9 ± 0.4d
10 224.3 ± 82.1a 0.182 ± 0.061 24.3 ± 0.2b 17.6 ± 0.6 200 91.2 ± 0.3d
15 200.0 ± 15.3a 0.145 ± 0.018 21.4 ± 1.1b 22.5 ± 1.1 300 92.5 ± 0.4d
20 243.0 ± 66.2a 0.170 ± 0.123 21.7 ± 0.1b 26.0 ± 4.0 400 93.5 ± 1.0d
30 271.5 ± 22.3a 0.180 ± 0.056 27.8 ± 0.6b 29.4 ± 3.0 600 95.1 ± 0.5d
40 272.9 ± 58.1a 0.254 ± 0.099 25.1 ± 0.0b 39.2 ± 2.1 800 95.1 ± 0.3d
50 278.4 ± 42.2 0.268 ± 0.092 24.9 ± 0.1b 39.0 ± 2.6 1000 96.1 ± 0.2d
Savory 5 233.1 ± 40.8a 0.171 ± 0.083 23.8 ± 1.5b 11.9 ± 0.0 100 88.1 ± 0.0d
10 230.7 ± 21.2a 0.136 ± 0.094 27.8 ± 4.2b 12.0 ± 0.1 200 94.0 ± 0.1d
15 182.7 ± 24.1a 0.087 ± 0.075 28.0 ± 5.8b 12.6 ± 0.1 300 95.8 ± 0.0d
20 220.8 ± 52.7a 0.092 ± 0.024 26.7 ± 1.3b 13.2 ± 0.2 400 96.7 ± 0.0d
30 188.0 ± 50.6a 0.098 ± 0.006 28.9 ± 4.5b 14.4 ± 0.6 600 97.6 ± 0.1d
40 139.4 ± 16.2a 0.135 ± 0.088 28.4 ± 1.6b 15.2 ± 0.4 800 98.1 ± 1.1d
50 229.3 ± 29.6a 0.149 ± 0.121 26.5 ± 3.5b 18.0 ± 0.2 1000 98.2 ± 0.1d
a,bThe results are given as mean of triplicate samples, each with six measurements. The same letters, in the same column indicate that no significant
differences were observed between the values (p50.05).
c,dThe results are given as mean of triplicate samples injections. The same letters, in the same column indicate that no significant differences were
observed between the values (p50.05).
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reported an increase in the particle size after freeze-drying
with the unmodified CS particles (Dudhania & Kosarajua,
2010). This was resulted from aggregation from the strong
inter- and intra-molecular hydrogen bonding, which was not
possible to breakdown even by vortex homogenization
(Dudhania & Kosarajua, 2010). This particles’ size increase
after freeze-drying process is also reported in essential oil
encapsulation (Wu et al., 2012).
Association efficiency and drug loading
It is known that CS in acidic media (pKa 6.5) can interact with
the negatively charged TPP, forming inter- and intra-molecu-
lar cross-linkages, yielding ionically cross-linked CS nano-
particles (Alonso & Sanchéz, 2003). This is a spontaneous
method for smaller nanoparticles formation with positive
charge, without using any organic solvent or surfactants
(Dudhania & Kosarajua, 2010). It is also known that the inter-
and intra-molecular linkages created between TPP and the
positively charged amino groups of CS are responsible for the
success of the gelation process (Calvo et al., 1997). In the
present study, it was described as a nanoparticulate system
able to encapsulate natural extracts. The particle size was
observed to be dependent on both CS and TPP concentrations
as described in the previous studies (Calvo et al., 1997), being
the minimum sizes obtained for the lowest CS and TPP
concentrations. Further experiments were conducted using the
mass ratio CS:TPP of 7:1, where the TPP final concentration
was 0.28 mg/mL and the CS final concentration was 2 mg/mL.
RA was selected as a model antioxidant in order to
investigate the feasibility of using CS and CS nanoparticles
for natural extract carriers. Association efficiency and theor-
etical antioxidant loading of these nanoparticles are dis-
played in Table 1.
The pH of the nanoparticles formation medium was
between 5.8 and 6.0, a pH value that favors the interaction
of RA and CS, thus reaching a maximum leading to the
entrapment of high amounts of RA. Among the different
samples considering the encapsulation of RA into CS
nanoparticles, it was observed similar association efficiency
around 50% (Table 1), for all the different loadings, no
significant differences were observed (p50.05). Higher
association efficiency was found for RA entrapment in
extracts of sage and savory, 96 and 98%, respectively, with
no significant differences observed (p50.05). This was in
accordance with previous reports (Silva et al., 2013). The
higher association efficiency in extracts nanoparticles may be
due to the different amounts of RA in CS nanoparticles inside
the extracts in CS nanoparticles (Table 2). Since competitive
interaction may be happen between phenolic (OH) of RA
and (P3P3O
5
10 ) groups of TPP for protonated amino groups of
CS resulting in low levels of particle formation compared
with the CS nanoparticles, this may be intensified with the
highest amount of RA and phenolic groups (Dudhania &
Kosarajua, 2010). This is in accordance with other studies that
encapsulate other phenolic compound, such as cathechin, in
CS nanoparticles (Dudhania & Kosarajua, 2010) and in other
nanoparticles (Peres et al., 2011).
The association efficiency values were higher than the
results for other natural extracts encapsulated into CS
nanoparticles, where the entrapment in CS-coated particles
was lower (around 50%) since active compound was lost dur-
ing immersion in CS (Deladino et al., 2008). This may be
due to the huge affinity of CS and two crude extracts.
The results were also higher than a study reported for
quercitrin encapsulation into nanoparticles, which was
only 40% (Kumari et al., 2011). However, the high associ-
ation efficiency reported in this study was in accordance to
other previous studies with the encapsulation of natural
antioxidants extracted from Ilex paraguariensis into CS
nanoparticles (Harris et al., 2011) and for the encapsulation
of antioxidant idebenone loaded into CS nanoparticles
(Amorim et al., 2010).
Figure 1. SEM micrographs of freeze-dried sage (a), savory-nanoparticles (b) both at 50% theoretical loading; and RA-nanoparticles (c), at 40%
theoretical loading.
Table 2. Association efficiency, theoretical loading, and final RA
















RA 51.2 ± 3.0 40 800 400
Sage 96.1 ± 0.2 50 1000 100
Savory 98.2 ± 0.1 50 1000 50
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In vitro rosmarinic acid release from CS nanoparticles
A fast release was observed during the in vitro release assays
which are in accordance with previous data (Silva et al.,
2013). The different RA antioxidant contents (in RA
nanoparticles, sage and savory nanoparticles) were released
in all the formulations freshly and freeze-dried within 60 min
with no significant differences (p50.05). An initial burst
effect was observed in the first 30 min with approximately
80% in sage nanoparticles and 100% in RA and savory
nanoparticles (in Supplemental information). The results
seem to demonstrate that a significant amount of RA or
extracts are initially associated with nanoparticles on their
surfaces by weak linkages to CS, which did not have the
necessary strength to entrap all the compounds. This repre-
sents that CS nanoparticulate system could retain the primary
structure of RA or extracts during encapsulation. The
protection release happens only for few minutes due to the
polymer network, which is in accordance with other studies
that encapsulate polyphenols from Ilex paraguariensis in CS
nanoparticles prepared also by ionic gelation, and a complete
release of 100% was demonstrated in the first 15 min (Harris
et al., 2011). In another study for quercetin encapsulation into
other nanocarriers, the release within the first 20 min was also
95% (Wu et al., 2008). Nevertheless, these results are different
from other works that demonstrates a complete release of
polyphenols of CS nanoparticles within 4 h (Dudhania &
Kosarajua, 2010). The efficient application of these nano-
carriers will certainly depend on the drug propose. CS
nanoparticles maintain their characteristics for these theoret-
ical loadings, and this confers them valuable properties, such
as protective and moisturizer, for the encapsulation of active
agents for cosmetic or ocular applications, since a rapid
released is intentional (Harris et al., 2011). However, for other
applications, like oral drug delivery, a slower release should
be optimized.
Thermal behavior by DSC analysis
The DSC measurements provide quantitative and qualitative
information about physical and chemical changes that involve
endothermic or exothermic processes, or changes in heat
capacity. Endothermic and exothermic peaks correspond to
transitions that absorb or release energy. DSC was performed
to understand the behavior of RA, sage and savory loaded and
unloaded CS nanoparticles and the thermograms are dis-
played in Table 3.
The same CS nanoparticles’ thermal behavior is observed
in all thermograms (Figures 2Ia and IIa and 3IIIa). In all CS
curves, an endothermic peak near 70 C can be ascribed to the
loss of water as reported previously (Guinesi & Cavalheiro,
2006). The endotherm of RA and sage and savory
nanoparticles showed different shift temperatures
(Figure 2Id, IId and IIId, respectively). This may be
accounted for the hydrophilic groups incorporated due to
RA that is in different amounts inside the extract particles.
Other previous studies also reported similar shifts in DSC
plots of CS and CS nanoparticles (Dudhania & Kosarajua,
2010; Vikas et al., 2004). It could also be seen that the peaks
of the complexes were shifted from those of physical mixture.
Peaks of physical mixture (Figure 2Ic, IIc, and IIIc) appeared
to be combinations of each material but they are different
from those of nanoparticles, probably because complexation
of polyelectrolytes, in accordance with other similar works
(Sarmento et al., 2006). Also, comparing endothermic peak of
antioxidant-loaded CS nanoparticles to the one obtained with
unloaded nanoparticles, the former started at higher tempera-
ture, which is a possible evidence of the presence of
antioxidants, once its decomposition started at higher tem-
perature when comparing with unloaded nanoparticles.
The RA-, sage- and savory-loaded sample showed a similar
shift of CS nanoparticles, which confirms that there are
no significant covalent interactions between antioxidants
and CS after encapsulation and cross-linking (Sarmento
et al., 2006).
Fourier-transform infrared analysis
Structural features and functional groups that represent
backbone produce characteristic and reproducible absorptions
in the spectrum, which can be analyzed by FTIR. With these
series of experiments, it was intended to monitorize the
complexation of contrary charged polyelectrolytes at specific
pH and stoichiometric relationship between the polyelectro-
lytes and the antioxidants in nanocarriers. For this concern
and to examine this relationship between components of
nanoparticulate systems, preliminary concerns were taken
over polyelectrolyte interactions and antioxidants’ entrap-
ment. It is well established that the carboxyl group (–COO) of
the anionic polymer may interact with the amino group
-NH3 of CS and forms an ionic complex between the two
compounds (Sarmento et al., 2006). RA displays a typical
vibrational absorption bands with the main bands located
between 1800 and 700 cm1 (Stehfest et al., 2004). The three
bands around 1605, 1520, and 1445 cm1 are due to the
presence of aromatic rings in the molecule indicating an
aromatic ring stretching (Stehfest et al., 2004). Other
evidences for phenolic groups were delivered through the
bands at 1360 and 1180 cm1 resulting from O–H and C–O
stretches (Stehfest et al., 2004). Therefore, the band at
1684 cm1 and the two shoulders recognized with this band
Table 3. Peak temperatures in the DSC thermograms collected from CS,




CS 102 ± 0.55 122 ± 1.20 131 ± 0.12
RA 112 ± 0.61 130 ± 0.73 141 ± 0.24
Sage 83 ± 0.27 108 ± 0.71 118 ± 0.93
Savory 103 ± 1.11 124 ± 0.82 137 ± 0.44
Free
RA 134 ± 0.13 144 ± 0.23 149 ± 0.25
Sage 140 ± 0.21 141 ± 0.14 145 ± 1.03
Savory 141 ± 0.53 154 ± 0.51 158 ± 0.81
Physical mixture
CS-RA 90 ± 0.38 122 ± 0.83 136 ± 0.14
147 ± 0.14 150 ± 0.70 154 ± 0.13
CS-sage 94 ± 0.91 121 ± 0.10 134 ± 0.50
147 ± 0.67 151 ± 0.63 155 ± 0.84
CS-savory 93 ± 0.70 121 ± 0.32 132 ± 0.32
145 ± 0.28 151 ± 0.64 154 ± 0.24
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result probably from the shifted bands due to the presence of
carboxylic acid groups and ester group 1725–1750 cm1
(Roeges, 1995). Figure 3 (I, II, and III) shows that all the
above characteristic peaks appear in the spectra of combined
drugs-loaded CS nanoparticles at the same wavenumber
indicating no modification or interaction between the drug
and the carrier. This is in accordance to previous work (Ajun
et al., 2009). Nevertheless, some peaks clearly decreased in
intensity, after the preparation of RA, sage and savory
nanoparticles. Particularly evident are the phenolic group
bands (1360 and 1180 cm1) in RA nanoparticles and this is
may be due to the highest amount of RA in these
Figure 2. I. Thermogram of CS empty
nanoparticles (a); thermogram of free RA
(b); thermogram of RA and CS physical
mixture (mixing ratio 1:1) (c); thermogram of
RA encapsulated in CS nanoparticles (at a
theoretical 40% loading) (d). II. Thermogram
of CS empty nanoparticles (a); thermogram
of free sage (b); thermogram of sage and CS
physical mixture (mixing ratio 1:1) (c);
thermogram of sage encapsulated in CS
nanoparticles (at a theoretical 50% loading)
(d). III. Thermogram of CS empty nanopar-
ticles (a); thermogram of free savouy (b);
thermogram of savory and CS physical mix-
ture (mixing ratio 1:1) (c); thermogram of
savory encapsulated in CS nanoparticles (at a
theoretical 50% loading) (d).
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nanoparticles, comparing with the inside content of RA in
extracts and nanoparticles. This effect is also reported by
some authors that developed a new FTIR method for the
characterization of RA in Lavandula officinalis cultures
(Stehfest et al., 2004). Nevertheless, it must be underlined that
this characteristic bands decrease observed in the nanoparti-
cles by FTIR analysis, and the decrease in antioxidant activity
(Antioxidant activity measurement section), may be due to the
partial retention of antioxidant before their complete release
(considering the theoretical loadings under studied). This is
Figure 3. I. Spectrum of CS empty nanopar-
ticles (a); spectrum of RA in a free form (b);
spectrum of physical mixture between CS-
unloaded nanoparticles and RA (mixing ratio
1:1) (c); spectrum of RA encapsulation into
CS nanoparticles (d). II. Spectrum of CS
empty nanoparticles (a); spectrum of sage in
a free form (b); spectrum of physical mixture
between CS unloaded nanoparticles and sage
(mixing ratio 1:1) (c); spectrum of sage
encapsulation into CS nanoparticles (d). III.
Spectrum of CS empty nanoparticles (a);
spectrum of savory in a free form (b);
spectrum of physical mixture between CS-
unloaded nanoparticles and savory (mixing
ratio 1:1) (c); spectrum of savory encapsula-
tion into CS nanoparticles (d).
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documented for other antioxidant nanoparticles studies, such
as essential oils (Wu et al., 2012). Also no new peaks
appeared in nanoencapsulation spectrum, and CS, RA, sage
and savory were mixed together physically without any
chemical reaction (Kumari et al., 2011).
Antioxidant activity measurement
For both methods, no significant differences were found for
antioxidant activity between the nanoformulations, before and
after freeze-drying processes (p50.05), except for savory
encapsulation. For these nanoparticles, a decrease in the
antioxidant activity was observed after freeze-drying, espe-
cially evident in the ORAC method. For the loading
concentrations of 5–15%, no antioxidant activity was found
by the ABTS or ORAC methods. This means that the
antioxidant activity is clearly compromised for these low
theoretical loadings. Considering both the extracts and RA
nanoparticles, the highest antioxidant activity is correlated
to the highest antioxidants concentrations (or higher % of
loading) (Table 4). Comparing RA, sage and savory in a free
form, it can be easily observed that RA has the highest
antioxidant activity, followed by sage that has the highest
content of RA (10%) and then savory with only (5%) of RA
content (Table 4). By the ABTS method, comparing the
antioxidant activity before and after the encapsulation
process, it is clear a decrease in the antioxidant activity
after the encapsulation. This proofs that the antioxidant
activity was decreased due to the partial entrapment effect of
the compounds. Nonetheless the particles still demonstrated
good antioxidant activity. This is in accordance to other
previous reports that have showed the same good antioxidant
effect of trolox in CS nanoparticles (Han et al., 2012). Other
good results were obtained for the CS encapsulation of
idebenone antioxidant (Amorim et al., 2010). Furthermore
and by ORAC, which is fluorimetric assay and a more
sensitive one, it can be easily observed that after the
encapsulation process the antioxidant activity is even lower
than the results achieved by ABTS (Table 4). These results are
in accordance with the previous studies with the encapsula-
tion of quercetin and rutin (Coneaca et al., 2009). This still
may be due to the nanoparticles entrapment of RA, in other
way, the antioxidant was not completely released. This partial
retention means that the compounds will take more time to
build up their specific activity. Nevertheless the nanosystems
with this entrapment effect still have good antioxidant
activity. Although even if the nanosystem antioxidant activity
is lower than the unloaded compounds, it is well known that
nanocarriers protect the antioxidants for degradation by
biological and enzymatic fluids, increasing their bioavailabil-
ity. The drug release can also be optimized to be even longer,
prolonged, and controlled in time, considering the proposed
application of these nanoparticles (Silva et al., 2011). This
makes the nanoencapsulation advantageous and necessary.
Besides no significant differences (p50.05) were achieved
in the all encapsulation process, and considering the same
loading concentrations of the RA and the extract nanoparti-
cles, it is also clear that RA in the extract nanoparticles is
lower in concentration than when it is purely encapsulated.
RA nanoparticles (40% loading) with 50% efficiency means
encapsulate, 0.4 mg/mL of RA. Nevertheless, sage or savory
nanoparticles (50% loading), with almost 100% association
efficiency (Table 1), the nanosystem encapsulates 1 mg/mL of
extract, but only 10 and 5% of RA (Table 2), for sage and
savory, respectively. It is also known and documented by our
group (Gião et al., 2009) that these crude extracts (sage and
savory) are complex natural matrixes with different antioxi-
dant contents (as protocatechuic acid, coumaric acid, gallic
acid, caffeic acid, ferulic acid, naringenin, quercetin,
isorhamnetin, chlorogenic acid, prunin, isoorientin, quercitrin,
and rutin). Nevertheless, when natural extracts are being
encapsulated, the pH value allows the great amount of RA
interaction with CS solution, and then the success of the
encapsulation. This means that some phenolic compounds are
present in the extracts, but are not negatively charged at
formation, medium, and pH, may be lost in the encapsulation
procedure. However, other antioxidant compounds in
extract nanoparticles that have a close pKa of RA are being
encapsulated adding a synergic antioxidant activity. This
justifies that with lower RA concentrations, the extracts have
the same antioxidant activity, being good vehicles of RA and
with good antioxidant synergic performance. Furthermore,
it is important to underline that RA-nanoparticles can
encapsulate with only 50% of association efficiency, which
means a huge waste of the compound. This could represent
that at this moment, for all the tests made for CS nanoparticles
Table 4. Antioxidant activity measurements by ABTS and ORAC, considering the 50% loading (m/m) sage and savory
nanoparticles; and 40% loading (m/m) of and RA nanoparticles for (n¼ 3).
ABTSx (eq [Asc. Ac.]g/L)/g extract ORACy (mmol/eq Trolox)/g extract
Fresh nanoparticles Freeze-dried nanoparticles Fresh nanoparticles Freeze-dried nanoparticles
NanoI
RA 0.0348 ± 0.0050a 0.0554 ± 0.0139a 4.8374 ± 0.1719b 3.6520 ± 0.1770b
Sage 0.0537 ± 0.0015c 0.0440 ± 0.0029c 0.6227 ± 0.0901d 0.4251 ± 0.0069d
Savory 0.0828 ± 0.0102e 0.0378 ± 0.0015f 1.5315 ± 0.2784g 0.4526 ± 0.0087h
FreeII
RA 0.0917 ± 0.0018 34.1218 ± 2.5733
Sage 0.1621 ± 0.0470 19.5924 ± 1.9791
Savory 0.1410 ± 0.0087 16.8117 ± 1.3605
The results are given as mean of triplicate samples, each with three measurements. The same letters, in the same line
indicate that no significant differences were observed between the fresh and freeze-dried process (p50.05). The values
are significantly different (p50.05) for the antioxidant methods (x, y) and for the encapsulation process (I, II).
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with sage or savory, they seem to be good vehicles for RA
incorporation and represent a more economically process
than nanoparticles with RA pure. Another advantage could be
added with the inclusion of biological activities of other
natural compounds that were incorporated at this pH value
in the nanoparticles. However, in vitro tests must be done in
order to guarantee that all the biological activities of the
extract and of RA are maintained.
Conclusion
The encapsulation of active agents in polymer matrix has
demonstrated to benefit from different perspectives, including
their protection from the surrounding medium or processing
conditions and their controlled release. The antioxidants
are sensitive biocompounds against adverse conditions like
mucosal enzymes and biological protective fluids. In this
study, CS nanoparticles incorporating RA, sage and savory
were prepared and characterized in order to ensure their best
size, efficient encapsulation, thermal stability, in vitro release,
and the high antioxidant activity performance.
The core of this work was to underline the potential
application of sage and savory for pharmaceutical or
biomedical formulations, considering the benefits of natural
extracts containing RA. Bearing in mind that natural
nanoparticles offer the most advanced treatment modality
for crude extracts incorporation. This could be a fundamental
alternative nanomedicine to enhanced antioxidant perform-
ance for oxidative stress conditions.
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